Skip to main content

Heart Transplant clinical trials at UCSD

3 in progress, 1 open to eligible people

Showing trials for
  • Allograft Dysfunction in Heart Transplant

    open to eligible people ages 18 years and up

    The investigators will evaluate for early evidence of cardiac allograft dysfunction by cardiac MRI and single cell sequencing to determine underlying molecular and macroscopic causes.

    La Jolla, California

  • Surveillance HeartCare® Outcomes Registry

    Sorry, in progress, not accepting new patients

    This is an observational registry to assess the clinical utility of surveillance using HeartCare testing services, in association with clinical care of heart transplant recipients.

    La Jolla, California and other locations

  • Tocilizumab in Cardiac Transplantation

    Sorry, not currently recruiting here

    The purpose of this research study is to see if a study drug called Tocilizumab will, when given with standard anti-rejection medicines, lead to better heart transplantation outcomes at 1 year after the transplant. Specifically, the investigators will evaluate whether taking tocilizumab leads to less rejection, less development of unwanted antibodies, and better heart function.

    La Jolla, California and other locations

Our lead scientists for Heart Transplant research studies include .

Last updated: